✦ LIBER ✦

A Phase I Study of High-dose BCNU, Etoposide and Escalating-dose Thiotepa (BTE) with Hematopoietic Progenitor Cell Support in Adults with Recurrent and High-risk Brain Tumors

✍ Scribed by Kyriakos P. Papadopoulos; Casilda Balmaceda; Michael Fetell; Elizabeth Kaufman; Linda T. Vahdat; Jeffrey Bruce; Michael Sisti; Steven Isaacson; Robert De LaPaz; David G. Savage; Andrea Troxel; Karen H. Antman; Charles S. Hesdorffer

Book ID: 110234913
Publisher: Springer US
Year: 1999
Tongue: English
Weight: 49 KB
Volume: 44
Category: Article
ISSN: 0167-594X
DOI: 10.1023/a:1006391619009

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High-dose thiotepa and etoposide-based r

High-dose thiotepa and etoposide-based regimens with autologous hematopoietic support for high-risk or recurrent CNS tumors in children and adults

✍ Papadopoulos, K P; Garvin, J H; Fetell, M; Vahdat, L T; Garrett, T J; Savage, D 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 63 KB

Phase I study of high-dose thiotepa with

Phase I study of high-dose thiotepa with busulfan, etoposide, and autologous stem cell support in children with disseminated solid tumors

✍ Pession, Andrea; Prete, Arcangelo; Locatelli, Franco; Bella, Santiago; Melchiond 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB 👁 2 views

Background. The aim of this phase I study was to define the maximum tolerated dose (MTD) of thiotepa (TT), administered with busulfan (BU) 480 mg/m 2 and etoposide 2,400 mg/m 2 , followed by autologous bone marrow transplantation (ABMT) or peripheral blood stem cell transplantation (APBSCT) support

Phase II study of high-dose thiotepa and

Phase II study of high-dose thiotepa and hematopoietic stem cell transplantation in children with solid tumors

✍ Lucidarme, N; Valteau-Couanet, D; Oberlin, O; Couanet, D; Kalifa, C; Beaujean, F 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 48 KB

A study of sequential high dose cyclopho

A study of sequential high dose cyclophosphamide and high dose carboplatin with peripheral stem-cell rescue in resistant or recurrent pediatric brain tumors

✍ N. K. Foreman; D. Schissel; Tuan Le; J. Strain; J. Fleitz; R. Quinones; R. Gille 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 232 KB

A phase I dose escalation study of high-

A phase I dose escalation study of high-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous peripheral blood stem cell transplantation (PBSCT) in patients with solid tumors and hematologic malignancies

✍ Demirer, T; lhan, O; Mandel, N M; Arat, M; Günel, N; Çelebi, H; Üstün, C; Akan, 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 70 KB

Repetitive high-dose therapy with cyclop

Repetitive high-dose therapy with cyclophosphamide, thiotepa and docetaxel with peripheral blood progenitor cell and filgrastim support for metastatic and locally advanced breast cancer: results of a phase I study

✍ Prince, H M; Rischin, D; Toner, G C; Seymour, J F; Blakey, D; Gates, P; Eerhard, 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 78 KB